ClinVar Genomic variation as it relates to human health
NM_000195.5(HPS1):c.1925del (p.Gly642fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000195.5(HPS1):c.1925del (p.Gly642fs)
Variation ID: 1068714 Accession: VCV001068714.15
- Type and length
-
Deletion, 1 bp
- Location
-
Cytogenetic: 10q24.2 10: 98418190 (GRCh38) [ NCBI UCSC ] 10: 100177947 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 10, 2021 Nov 24, 2024 Oct 31, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000195.5:c.1925del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000186.2:p.Gly642fs frameshift NM_000195.3:c.1925delG NM_000195.4:c.1925delG NM_001311345.2:c.953del NP_001298274.1:p.Gly318fs frameshift NM_001322476.2:c.1925del NP_001309405.1:p.Gly642fs frameshift NM_001322477.2:c.1925del NP_001309406.1:p.Gly642fs frameshift NM_001322478.2:c.1826del NP_001309407.1:p.Gly609fs frameshift NM_001322479.2:c.1826del NP_001309408.1:p.Gly609fs frameshift NM_001322480.2:c.1664del NP_001309409.1:p.Gly555fs frameshift NM_001322481.2:c.1664del NP_001309410.1:p.Gly555fs frameshift NM_001322482.2:c.1565del NP_001309411.1:p.Gly522fs frameshift NM_001322483.2:c.1556del NP_001309412.1:p.Gly519fs frameshift NM_001322484.2:c.1556del NP_001309413.1:p.Gly519fs frameshift NM_001322485.2:c.1457del NP_001309414.1:p.Gly486fs frameshift NM_001322487.2:c.953del NP_001309416.1:p.Gly318fs frameshift NM_001322489.2:c.953del NP_001309418.1:p.Gly318fs frameshift NC_000010.11:g.98418192del NC_000010.10:g.100177949del NG_009646.1:g.33758del LRG_562:g.33758del LRG_562t1:c.1925del LRG_562p1:p.Gly642fs - Protein change
- G318fs, G486fs, G519fs, G522fs, G555fs, G609fs, G642fs
- Other names
-
p.Gly642Glufs*83
- Canonical SPDI
- NC_000010.11:98418189:CCC:CC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
HPS1 | - | - |
GRCh38 GRCh37 |
1099 | 1133 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Oct 31, 2024 | RCV001380350.14 | |
Likely pathogenic (1) |
criteria provided, single submitter
|
Oct 21, 2023 | RCV003469647.1 | |
HPS1-related disorder
|
Likely pathogenic (1) |
no assertion criteria provided
|
Sep 17, 2024 | RCV004754745.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Oct 21, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Hermansky-Pudlak syndrome 1
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004199920.1
First in ClinVar: Dec 30, 2023 Last updated: Dec 30, 2023 |
|
|
Pathogenic
(May 07, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001578354.4
First in ClinVar: May 10, 2021 Last updated: Feb 28, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the HPS1 protein. Other variant(s) that result in … (more)
For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the HPS1 protein. Other variant(s) that result in a similarly extended protein product (p.Tyr645Thrfs*80) have been determined to be pathogenic (PMID: 30387913, 19665357). This suggests that these extensions are likely to be causative of disease. This variant has not been reported in the literature in individuals with HPS1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a frameshift in the HPS1 gene (p.Gly642Glufs*83). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 59 amino acid(s) of the HPS1 protein and extend the protein by 23 additional amino acid residues. (less)
|
|
Likely pathogenic
(Oct 31, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001789335.5
First in ClinVar: Aug 21, 2021 Last updated: Nov 10, 2024 |
Comment:
Has not been previously published as pathogenic or benign to our knowledge; Frameshift variant predicted to result in abnormal protein length as the last 59 … (more)
Has not been previously published as pathogenic or benign to our knowledge; Frameshift variant predicted to result in abnormal protein length as the last 59 amino acids are replaced with 82 different amino acids, and other similar variants have been reported in HGMD; Not observed at significant frequency in large population cohorts (gnomAD) (less)
|
|
Likely pathogenic
(Apr 03, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV005413955.1
First in ClinVar: Nov 24, 2024 Last updated: Nov 24, 2024 |
Comment:
PM2_moderate, PVS1_strong
Number of individuals with the variant: 1
|
|
Likely pathogenic
(Sep 17, 2024)
|
no assertion criteria provided
Method: clinical testing
|
HPS1-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005363046.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The HPS1 c.1925delG variant is predicted to result in a frameshift and premature protein termination (p.Gly642Glufs*83). XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX which is predicted to result in a frameshift … (more)
The HPS1 c.1925delG variant is predicted to result in a frameshift and premature protein termination (p.Gly642Glufs*83). XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX which is predicted to result in a frameshift and extension of the normal open reading frame (p.Gly642Glufs*83) (the canonical stop codon is at position p.701). To our knowledge, this variant has not been reported in the literature. However, this variant is similar in form and gene position to other reported variants (c.1887delC,p.Val630Serfs*95; c.1932delC,p.Tyr645Thrfs*80) in individuals with Oculocutaneous albinism or Hermansky‐Pudlak syndrome (Wei et al. 2011. PubMed ID: 21458243; Wei et al. 2018. PubMed ID: 30387913). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic or likely pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/1068714/). Taken together, this variant is interpreted as likely pathogenic. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Genetic variants and mutational spectrum of Chinese Hermansky-Pudlak syndrome patients. | Liu T | Pigment cell & melanoma research | 2021 | PMID: 32725903 |
Instability of BLOC-2 and BLOC-3 in Chinese patients with Hermansky-Pudlak syndrome. | Wei A | Pigment cell & melanoma research | 2019 | PMID: 30387913 |
The first case report of a Chinese Hermansky-Pudlak syndrome patient with a novel mutation on HPS1 gene. | Wei A | Journal of dermatological science | 2009 | PMID: 19665357 |
Text-mined citations for rs2136083690 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.